Published in J Cutan Pathol on October 01, 2005
So called 'de novo intraepidermal epithelioid melanocytic dysplasia' is melanoma in situ. J Cutan Pathol (2007) 1.92
Melanocytic nevi simulant of melanoma with medicolegal relevance. Virchows Arch (2007) 1.41
Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol (2009) 23.08
Melanoma. N Engl J Med (2006) 8.80
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients. Proc Natl Acad Sci U S A (2003) 5.49
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients. Proc Natl Acad Sci U S A (2008) 4.43
Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood (2010) 4.28
Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell (2012) 4.04
Variability in nomenclature used for nevi with architectural disorder and cytologic atypia (microscopically dysplastic nevi) by dermatologists and dermatopathologists. J Cutan Pathol (2004) 3.43
B-lymphocyte contributions to human autoimmune disease. Immunol Rev (2008) 2.89
Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol (2003) 2.81
An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background. Nature (2012) 2.35
Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. J Clin Oncol (2010) 2.30
Pigmented epithelioid melanocytoma: a low-grade melanocytic tumor with metastatic potential indistinguishable from animal-type melanoma and epithelioid blue nevus. Am J Surg Pathol (2004) 2.29
Pyoderma gangrenosum: a review. J Cutan Pathol (2003) 2.23
Congenital melanocytic nevi: clinical and histopathologic features, risk of melanoma, and clinical management. J Am Acad Dermatol (2005) 2.22
Incidence of nephrogenic systemic fibrosis at two large medical centers. Radiology (2008) 2.16
Calciphylaxis: emerging concepts in prevention, diagnosis, and treatment. Semin Dial (2002) 2.16
Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes. Mod Pathol (2005) 2.12
Atypical lymphocytic lobular panniculitis. J Cutan Pathol (2004) 2.02
Unusual variants of malignant melanoma. Mod Pathol (2006) 1.93
Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database. J Clin Oncol (2011) 1.78
Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma. Cancer Immun (2009) 1.74
Cutaneous vasculitis: a review. J Cutan Pathol (2003) 1.74
Biology of desmoplastic melanoma: a case-control comparison with other melanomas. J Clin Oncol (2005) 1.71
State of the art, nomenclature, and points of consensus and controversy concerning benign melanocytic lesions: outcome of an international workshop. Adv Anat Pathol (2010) 1.68
EANM-EORTC general recommendations for sentinel node diagnostics in melanoma. Eur J Nucl Med Mol Imaging (2009) 1.68
A phase I study of interleukin 12 with trastuzumab in patients with human epidermal growth factor receptor-2-overexpressing malignancies: analysis of sustained interferon gamma production in a subset of patients. Clin Cancer Res (2004) 1.55
Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcgammaRI, FcgammaRIII, and FcgammaRIV. Blood (2008) 1.55
Pigmented epithelioid melanocytoma: report of first Japanese cases previously diagnosed as cellular blue nevus. J Cutan Pathol (2009) 1.48
Genetic and morphologic features for melanoma classification. Pigment Cell Melanoma Res (2010) 1.47
T-cell prolymphocytic leukemia: an aggressive T cell malignancy with frequent cutaneous tropism. J Am Acad Dermatol (2006) 1.46
Photodynamic therapy for cutaneous proliferative vascular tumors in a mouse model. J Invest Dermatol (2003) 1.42
Light-chain-restricted plasmacellular infiltrates in necrobiosis lipoidica -- a clue to an underlying monoclonal gammopathy. J Cutan Pathol (2005) 1.39
Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell vaccines early after allogeneic stem cell transplantation. Proc Natl Acad Sci U S A (2009) 1.34
Current concepts of metastasis in melanoma. Expert Rev Dermatol (2008) 1.34
PTEN expression in normal skin, acquired melanocytic nevi, and cutaneous melanoma. J Am Acad Dermatol (2003) 1.33
Milk fat globule EGF-8 promotes melanoma progression through coordinated Akt and twist signaling in the tumor microenvironment. Cancer Res (2008) 1.29
The diagnostic performance of expert dermoscopists vs a computer-vision system on small-diameter melanomas. Arch Dermatol (2008) 1.28
Malignant adnexal neoplasms. Mod Pathol (2006) 1.26
Long-term blood vessel removal with combined laser and topical rapamycin antiangiogenic therapy: implications for effective port wine stain treatment. Lasers Surg Med (2010) 1.21
SOX2 contributes to melanoma cell invasion. Lab Invest (2011) 1.21
Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial. Ann Rheum Dis (2011) 1.20
Melanoma in the young: differences and similarities with adult melanoma: a case-matched controlled analysis. Cancer (2007) 1.18
Isolation, characterization, and in vitro propagation of infantile hemangioma stem cells and an in vivo mouse model. J Hematol Oncol (2011) 1.18
Pilomatrix carcinomas contain mutations in CTNNB1, the gene encoding beta-catenin. J Cutan Pathol (2005) 1.17
Cutaneous CD4+ CD56+ hematologic malignancies. J Am Acad Dermatol (2010) 1.14
Progress in the understanding of the pathology and pathogenesis of cutaneous drug eruptions : implications for management. Am J Clin Dermatol (2003) 1.13
Novel genetic mutations in a sporadic port-wine stain. JAMA Dermatol (2014) 1.12
Proliferative nodules arising within congenital melanocytic nevi: a histologic, immunohistochemical, and molecular analyses of 43 cases. Am J Surg Pathol (2011) 1.11
Infantile hemangiomas are arrested in an early developmental vascular differentiation state. Mod Pathol (2004) 1.10
Utility of lesion diameter in the clinical diagnosis of cutaneous melanoma. Arch Dermatol (2008) 1.10
Basosquamous carcinoma. J Am Acad Dermatol (2009) 1.10
Idiopathic pulmonary fibrosis related to endothelial injury and antiendothelial cell antibodies. Hum Immunol (2006) 1.10
Vascular tumors of infancy and childhood: beyond capillary hemangioma. Cardiovasc Pathol (2006) 1.09
Congenital and infantile melanoma: review of the literature and report of an uncommon variant, pigment-synthesizing melanoma. J Am Acad Dermatol (2002) 1.08
Drug-induced linear IgA bullous dermatosis. J Dermatol (2005) 1.07
A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics. J Am Acad Dermatol (2011) 1.06
Atypical and malignant hidradenomas: a histological and immunohistochemical study. Mod Pathol (2009) 1.06
De novo intraepidermal epithelioid melanocytic dysplasia: an emerging entity. J Cutan Pathol (2009) 1.06
Expression of prox1, lymphatic endothelial nuclear transcription factor, in Kaposiform hemangioendothelioma and tufted angioma. Am J Surg Pathol (2010) 1.04
The nonrandom distribution of facial hemangiomas. Arch Dermatol (2003) 1.03
Pigmented epithelioid melanocytoma: favorable outcome after 5-year follow-up. Am J Surg Pathol (2009) 1.03
AJCC melanoma staging update: impact on dermatopathology practice and patient management. J Cutan Pathol (2011) 1.02
Docetaxel (taxotere) induced subacute cutaneous lupus erythematosus: report of 4 cases. J Rheumatol (2004) 1.02
Recurrent nevus phenomenon: a clinicopathologic study of 357 cases and histologic comparison with melanoma with regression. Mod Pathol (2009) 1.02
Markers and tissue resources for melanoma: meeting report. Cancer Res (2006) 1.01
Apocrine-eccrine carcinomas: molecular and immunohistochemical analyses. PLoS One (2012) 1.01
Prox-1 promotes invasion of kaposiform hemangioendotheliomas. J Invest Dermatol (2008) 1.01
Henoch-Schonlein purpura secondary to subacute bacterial endocarditis. Cutis (2002) 1.00
Molecular mechanisms of metastasis. Cancer Metastasis Rev (2006) 1.00
The dermatopathologic manifestations of hepatitis C infection: a clinical, histological, and molecular assessment of 35 cases. Hum Pathol (2003) 1.00
Non-thermal, pulsed electric field cell ablation: A novel tool for regenerative medicine and scarless skin regeneration. Technology (Singap World Sci) (2013) 0.99
Histomorphologic assessment and interobserver diagnostic reproducibility of atypical spitzoid melanocytic neoplasms with long-term follow-up. Am J Surg Pathol (2014) 0.99
Immunoglobulin-A--associated small-vessel vasculitis: a 10-year experience at the Massachusetts General Hospital. J Am Acad Dermatol (2011) 0.99
B lymphocytes differentially influence acute and chronic allograft rejection in mice. J Immunol (2011) 0.98
Epstein-Barr virus- and human herpesvirus 8-associated primary cutaneous plasmablastic lymphoma in the setting of renal transplantation. J Cutan Pathol (2005) 0.97
Protocol for the examination of specimens from patients with melanoma of the skin. Arch Pathol Lab Med (2009) 0.97
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 13-2004. A newborn girl with a large cutaneous lesion, thrombocytopenia, and anemia. N Engl J Med (2004) 0.96
Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions. Am J Surg Pathol (2007) 0.96
Bullous reactions to bedbug bites reflect cutaneous vasculitis. Am J Med (2012) 0.96
The distribution of immunomodulatory cells in the lungs of patients with idiopathic pulmonary fibrosis. Mod Pathol (2011) 0.96
Prognosticators of melanoma, the melanoma report, and the sentinel lymph node. Mod Pathol (2006) 0.95
Interface dermatitis. Arch Pathol Lab Med (2008) 0.95
Endobronchial presentation of Hodgkin lymphoma: a review of the literature. Ann Thorac Surg (2003) 0.95
Skin biopsy for inflammatory and common neoplastic skin diseases: optimum time, best location and preferred techniques. A critical review. J Cutan Pathol (2009) 0.95
Progress in melanoma histopathology and diagnosis. Hematol Oncol Clin North Am (2009) 0.95
Prevalence of melanoma clinically resembling seborrheic keratosis: analysis of 9204 cases. Arch Dermatol (2002) 0.94
Topical rapamycin suppresses the angiogenesis pathways induced by pulsed dye laser: molecular mechanisms of inhibition of regeneration and revascularization of photocoagulated cutaneous blood vessels. Lasers Surg Med (2012) 0.93
Endocrine mucin-producing sweat gland carcinoma: twelve new cases suggest that it is a precursor of some invasive mucinous carcinomas. Am J Surg Pathol (2005) 0.93
Increased diagnosis of thin superficial spreading melanomas: A 20-year study. J Am Acad Dermatol (2011) 0.93
Pigmented purpuric dermatosis: classification by phenotypic and molecular profiles. Am J Clin Pathol (2007) 0.93